Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
ALSA Holdings is a Europe-based biotechnology investment firm with a focus on novel therapeutics at preclinical POC or early clinical development stage. The firm is managed by the founder and ex-CEO of Novotech, a leading midsize clinical CRO. The firm has considerable expertise and experience in clinical development and are an active investor. They have no geographic or therapeutic area constraints and are equally open to seeding new companies, as investing in later syndicated rounds, or as a sole investor.
Contact Phone:
Contact Email:
Name | Price |
---|
Name | Size | Announced Date |
---|